These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 341313)

  • 21. Dextroamphetamine: cognitive and behavioral effects in normal and hyperactive boys and normal adult males.
    Rapoport JL; Buchsbaum MS; Weingartner H
    Psychopharmacol Bull; 1980 Jan; 16(1):21-3. PubMed ID: 7360831
    [No Abstract]   [Full Text] [Related]  

  • 22. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
    Nolan EE; Gadow KD; Sprafkin J
    Pediatrics; 1999 Apr; 103(4 Pt 1):730-7. PubMed ID: 10103294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
    Conners CK
    Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
    [No Abstract]   [Full Text] [Related]  

  • 24. Response to Brasić (2007): psychomotor study of children with ADHD.
    Pedersen SJ
    Percept Mot Skills; 2008 Jun; 106(3):891-2. PubMed ID: 18712212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep amphetamine effects in MBDS and normal subjects.
    Feinberg I; Hibi S; Braun M; Cavness C; Westerman G; Small A
    Arch Gen Psychiatry; 1974 Nov; 31(5):723-31. PubMed ID: 4374157
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
    Solanto MV
    Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
    [No Abstract]   [Full Text] [Related]  

  • 29. Aggression in hyperactive boys: response to d-amphetamine.
    Amery B; Minichiello MD; Brown GL
    J Am Acad Child Psychiatry; 1984 May; 23(3):291-4. PubMed ID: 6736494
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response.
    Pearson DA; Lane DM; Santos CW; Casat CD; Jerger SW; Loveland KA; Faria LP; Mansour R; Henderson JA; Payne CD; Roache JD; Lachar D; Cleveland LA
    J Am Acad Child Adolesc Psychiatry; 2004 Jun; 43(6):686-98. PubMed ID: 15167085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy.
    Zametkin A; Rapoport JL; Murphy DL; Linnoila M; Ismond D
    Arch Gen Psychiatry; 1985 Oct; 42(10):962-6. PubMed ID: 3899047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of methylphenidate and dextroamphetamine on the motor activity level of hyperactive children.
    Borcherding BG; Keysor CS; Cooper TB; Rapoport JL
    Neuropsychopharmacology; 1989 Dec; 2(4):255-63. PubMed ID: 2692588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet MAO and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity.
    Shekim WO; Bylund DB; Alexson J; Glaser RD; Jones SB; Hodges K; Perdue S
    Psychiatry Res; 1986 Jun; 18(2):179-88. PubMed ID: 3725999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet alpha 2-adrenergic receptor binding and the effects of d-amphetamine in boys with attention deficit hyperactivity disorder.
    Shekim WO; Bylund DB; Hodges K; Glaser R; Ray-Prenger C; Oetting G
    Neuropsychobiology; 1994; 29(3):120-4. PubMed ID: 8022532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: a secondary analysis.
    Lopez FA; Ginsberg LD; Arnold V
    Postgrad Med; 2008 Sep; 120(3):89-102. PubMed ID: 18824828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of ADDH in mentally retarded children: a preliminary study.
    Payton JB; Burkhart JE; Hersen M; Helsel WJ
    J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):761-7. PubMed ID: 2676965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD.
    James RS; Sharp WS; Bastain TM; Lee PP; Walter JM; Czarnolewski M; Castellanos FX
    J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1268-76. PubMed ID: 11699800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.
    Samuels JA; Franco K; Wan F; Sorof JM
    Pediatr Nephrol; 2006 Jan; 21(1):92-5. PubMed ID: 16254730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computer analyzed EEG in amphetamine-responsive hyperactive children.
    McIntyre HB; Firemark HM; Cho AK; Bodner L; Gomez M
    Psychiatry Res; 1981 Apr; 4(2):189-97. PubMed ID: 6939009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive and behavioral effects of multilayer-release methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder.
    Schachar R; Ickowicz A; Crosbie J; Donnelly GA; Reiz JL; Miceli PC; Harsanyi Z; Darke AC
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):11-24. PubMed ID: 18294084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.